Showing results (171-180 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|July 28, 2020
The Authors RespondChristina H Sherrill, Christopher T Houpt, Elisabeth M Dixon, et al.Journal of Managed Care & Specialty Pharmacy|August 12, 2020
AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and ReimbursementJournal of Managed Care & Specialty Pharmacy|March 29, 2023
Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years in the United StatesMichelle Vu, Amy M Duhig, Abhishek Tibrewal, et al.Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burdenShirley P Huang, Maral DerSarkissian, Yuqian M Gu, et al.Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Understanding differences between what alternate propensity score methods estimateAnirban Basu, Aig Unuigbe, Cristina MasseriaJournal of Managed Care & Specialty Pharmacy|March 29, 2023
Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapyEbuwa Igho-Osagie, Amy Puenpatom, Marissa Grifasi Williams, et al.Journal of Managed Care & Specialty Pharmacy|April 30, 2023
Payer perceptions and use of value assessment tools in the United StatesKimberly Westrich, Tasmina Hydery, Vyishali Dharbhamalla, et al.Journal of Managed Care & Specialty Pharmacy|April 30, 2023
Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning modelMarianna Bruno, Richard Sheer, Casey Reed, et al.Journal of Managed Care & Specialty Pharmacy|April 30, 2023
The association between cost sharing, prior authorization, and specialty drug utilization: A systematic reviewWesam W Ismail, Matthew J Witry, Julie M UrmieJournal of Managed Care & Specialty Pharmacy|September 20, 2022
Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspectiveDavid E Kaplan, Marina Serper, Ankita Kaushik, et al.Pageof 185